Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS

Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Ashland (ASH) Tops Q3 EPS by 2c; offers guidance
• Sound Finl Bancorp (SFBC) Tops Q2 EPS by 98c
• Qorvo (QRVO) Tops Q1 EPS by 52c